Stephen Ansell
Professor of Medicine, Chair of Division of Hematology
Mayo Clinic · Rochester, United States
Chair of Division of Hematology at Mayo Clinic. Primary expertise in Hodgkin lymphoma, Waldenstrom macroglobulinemia, and tumor microenvironment. Contributes to MCL research through immunotherapy and microenvironment studies.
High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes.
American journal of hematology · Mar 27, 2026
Family history of haematological malignancy and prognosis across non-Hodgkin lymphoma subtypes.
British journal of haematology · Mar 10, 2026
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma.
Cell reports. Medicine · Sep 16, 2025